Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.

Disease markers - 1 Jan 2013

AbdRaboh Naglaa R, Shehata Hanan H, Ahmed Manal B, Bayoumi Fatehia A

Abstract excerpt

BACKGROUND: Polymorphism of the genes of Human Epidermal growth factor receptor1 (HER1) and receptor2 (HER2) have been reported to be linked to pathogenesis of several malignant tumors but still there is contradiction regarding their association with breast cancer. OBJECTIVE: In this case control study we aimed to analyze the frequency of HER1 R497K (rs 11543848) and HER2 I655V (rs 1136201) Polymorphisms in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Carcinoma
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genetic Association Studies

Share to Mutation, Missense

Share to Polymorphism, Restriction Fragment Length

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 23594562
DOI: 10.3233/DMA-130989
PMCID: PMC3810125

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.PMID 23594562Read ↗

Her2 Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies.Semantic proximity Read ↗

Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.Semantic proximity Read ↗

HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.Semantic proximity Read ↗

HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.Semantic proximity Read ↗

HER-2/neu Ile655Val polymorphism and the risk of breast cancer.Semantic proximity Read ↗

Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.Semantic proximity Read ↗

A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.Semantic proximity Read ↗

Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer.Semantic proximity Read ↗

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.Semantic proximity Read ↗

HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.